Xultophy® 100/3.6 is a once-daily combination of a basal insulin (insulin degludec) and a GLP-1 receptor agonist (liraglutide) for adults with type 2 diabetes.1
Xultophy® 100/3.6 [ZUL-to-fye] is a once-daily injectable to improve glycemic control for adults with type 2 diabetes as an adjunct to diet and exercise.1
Xultophy® 100/3.6 [ZUL-to-fye] is a once daily injectable, for adults with type 2 diabetes as an adjunct to diet and exercise.1
What is Xultophy® 100/3.6?
Information to know when filling prescriptions
Don’t forget to order NovoFine® Plus 32g pen needlesa
NovoFine® Plus: our shortest and thinnest needle available is ultra-strong and designed to resist bending or breaking.
aNeedles are sold separately and may require a prescription in some states.